Soyoung Kwon serves as Executive at Aptevo Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Soyoung Kwon has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 8, 2024 involved exercising options for 213 shares valued at $0.
Soyoung Kwon currently holds 801 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Soyoung Kwon has been a net neutral trader of APVO stock. They have purchased $0 and sold $0 worth of shares.
Soyoung Kwon's most recent insider trade was on Aug 8, 2024, when they sold 213 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 42 |
| $N/A |
| Discretionary |
| Mar 3, 2024 | APVO | $0 | Option Exercise | 3,667 | $N/A | Discretionary |
| Mar 2, 2024 | APVO | $0 | Option Exercise | 3,667 | $N/A | Discretionary |
| Aug 8, 2023 | APVO | $0 | Option Exercise | 9,375 | $N/A | Discretionary |
| May 31, 2023 | APVO | $0 | Option Exercise | 1,834 | $N/A | Discretionary |
| Mar 3, 2023 | APVO | $0 | Option Exercise | 3,666 | $N/A | Discretionary |
| Jun 1, 2022 | APVO | $0 | Option Exercise | 1,833 | $N/A | Discretionary |